HOME
ABOUT IAC
CONTACT
A-Z INDEX
DONATE
SHOP
SUBSCRIBE
Immunize.org logo formerly Immunization Action Coalition (IAC)
IAC Home
|
News & Information
|
Official Releases
|
CDC

Official Releases

Centers for Disease Control and Prevention
February 2023
2023 U.S. Recommended Immunization Schedule for Adults Aged 19 Years or Older
CDC - 2/10/23
 
2023 U.S. Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger
CDC - 2/10/23
 
December 2022
CDC expands updated COVID-19 vaccines to include children ages 6 months through 5 years 
CDC - 12/9/22
 
November 2022
Updated Vaccine Information Statement (VIS) for smallpox/monkeypox vaccine (Jynneos) released 
CDC - 11/14/22
 
October 2022
CDC allows those 18 years and older option to receive a Novavax monovalent booster instead of an updated (bivalent) Pfizer-BioNTech or Moderna booster if they have completed primary series vaccination but have not previously received a COVID-19 booster.
CDC - 10/19/22
 
CDC recommends expanding the use of updated (bivalent) COVID-19 vaccines (Pfizer-BioNTech for children ages 5 through 11 years, Moderna for children and adolescents ages 6 through 11 years) to children ages 5 through 11 years. 
CDC - 10/12/22
 
September 2022
US joins list of 30 countries that meet WHO criteria for circulating vaccine-derived poliovirus (cVDPV)
CDC - 9/13/22
 
CDC recommends the first updated COVID-19 booster (bivalent booster) 
CDC - 9/1/22
 
August 2022
Updated Vaccine Information Statement (VIS) for smallpox/monkeypox vaccine (Jynneos) released
CDC - 8/23/22
 
CDC recommends Novavax COVID-19 vaccine for use in adolescents 12 years through 17 years as a primary series option.
CDC - 8/22/22
 
June 2022
New Vaccine Information Statement (VIS) posted for Ebola vaccine
CDC - 6/30/22
 
CDC endorsed ACIP recommendation of Moderna’s COVID-19 vaccine for those 6 through 17 years of age, in addition to its already recommended use in children 6 months through 5 years and adults 18 years and older 
CDC – 6/24/22
 
CDC endorsed the ACIP recommendation that all children 6 months through 5 years of age should receive a Moderna or Pfizer-BioNTech COVID-19 vaccine.  All children, including children who have already had COVID-19, should get vaccinated
CDC – 6/18/22
 
Updated Vaccine Information Statement (VIS) for rabies vaccine released
CDC – 6/2/22
 
New Vaccine Information Statement (VIS) for smallpox/monkeypox vaccine (Jynneos) released 
CDC - 6/1/22
 
May 2022
CDC recommends that children ages 5 through 11 years should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series, strengthens its recommendation that those 12 and older who are immunocompromised and those 50 and older should receive a second booster dose at least 4 months after their first 
CDC – 5/19/22
 
March 2022
CDC recommends additional boosters for certain Individuals
CDC – 3/29/22
 
February 2022
2022 U.S. Recommended Immunization Schedule for Adults Aged 19 Years or Older
CDC – 2/18/22
 
2022 U.S. Recommended Immunization Schedules for Children and Adolescents Aged 18 Years or Younger
CDC – 2/18/22
 
CDC's latest information about Vaccine Information Statements (VIS) currently under development or newly released.
CDC – 2/4/22
 
New Vaccine Information Statement (VIS) for pneumococcal conjugate vaccine (PCV13, PCV15, and PCV20) released.
CDC – 2/4/22
 
Updated VIS for recombinant zoster (shingles) vaccine released.
CDC – 2/4/22
 
January 2022
CDC endorses ACIP recommendation to expand eligibility of booster doses to those 12 to 15 years old. CDC recommends that all adolescents age 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series.
CDC - 1/5/22
 
CDC recommends Pfizer-BioNTech booster 5 months after completing primary series. CDC recommends moderately or severely immunocompromised 5–11-year-olds receive an additional primary dose of Pfizer-BioNTech COVID-19 vaccine 28 days after their second shot.
CDC - 1/4/22
 
December 2021
New Dengue Vaccine Information Statement (VIS) released.
CDC – 12/17/21
CDC expands booster recommendations to adolescents ages 16 and 17 if at least six months after their initial Pfizer vaccination series.
CDC – 12/9/21
November 2021
CDC recommends everyone 18 years of age and older get a booster shot when they are 6 months after their initial Pfizer or Moderna series or 2 months after their initial J&J vaccine.
CDC – 11/29/21
October 2021
Updated Hepatitis A Vaccine Information Statement released
CDC VIS – 10/15/21
Updated Hepatitis B Vaccine Information Statement released
CDC VIS – 10/15/21
Updated Rotavirus Vaccine Information Statement released
CDC VIS – 10/15/21
Updated, "Your Child’s First Vaccines", multiple pediatric vaccines Vaccine Information Statement released
CDC VIS – 10/15/21
August 2021
Updated DTaP (diphtheria, tetanus, pertussis) Vaccine Information Statement released
CDC VIS – 8/6/21
Updated Hib (Haemophilus influenzae type b) Vaccine Information Statement released
CDC VIS – 8/6/21
Updated HPV (Human Papillomavirus) Vaccine Information Statement released
CDC VIS – 8/6/21
Updated Live, Intranasal Influenza Vaccine Information Statement released
CDC VIS – 8/6/21
Updated Inactivated Influenza Vaccine Information Statement released
CDC VIS – 8/6/21
Updated MMR (Measles, Mumps, Rubella) Vaccine Information Statement released
CDC VIS – 8/6/21
Updated MMRV (Measles, Mumps, Rubella & Varicella) Vaccine Information Statement released
CDC VIS – 8/6/21
Updated Meningococcal ACWY Vaccine Information Statement released
CDC VIS – 8/6/21
Updated Meningococcal B Vaccine Information Statement released
CDC VIS – 8/6/21
Updated Pneumococcal Conjugate (PCV13) Vaccine Information Statement released
CDC VIS – 8/6/21
Updated Polio Vaccine Information Statement released
CDC VIS – 8/6/21
Updated Tdap (Tetanus, Diphtheria, Pertussis) Vaccine Information Statement released
CDC VIS – 8/6/21
Updated Td (Tetanus, Diphtheria) Vaccine Information Statement released
CDC VIS – 8/6/21
Updated Varicella (Chickenpox) Vaccine Information Statement released
CDC VIS – 8/6/21
April 2021
CDC and FDA lift recommended pause of use of Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. after a review by ACIP. Use of vaccine should resume. EUA fact sheets for Johnson & Johnson (Janssen) COVID-19 Vaccine revised.
CDC/FDA - 4/23/21
CDC and FDA have recommended a pause in the use of the Janssen (Johnson & Johnson) COVID-19 vaccine in the United States out of an abundance of caution.
CDC/FDA - 4/13/21
February 2021
2021 U.S. Recommended Immunization Schedules for Children and Adolescents Age 18 Years or Younger
ACIP/AAP/AAFP/ACOG - 2/12/21
2021 U.S. Recommended Immunization Schedule for Adults Aged 19 Years or Older
ACIP/AAFP/ACP/ACOG/ACNM - 2/12/21
VIEW ALL:
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
 
This page was updated on February 10, 2023.
This page was reviewed on February 10, 2023.
Official Releases
- ACIP: Advisory Committee on Immunization Practices
- CDC: Centers for Disease Control and Prevention
- FDA: Food and Drug Administration
View All Recent Official Releases
News & Information Home
Additional CDC Information
CDC Materials
CDC Schedules
CDC Web Sections
Vaccine Policy & Licensure
CDC's Free Email Subscription Service
Complete a subscription profile, and CDC sends an alert by email when new information on the topics you pick (e.g., VISs, schedules, ACIP recommendations, statistics, registries, news) have been updated on the agency's website.
 
- Guide to immunize.org -
A-Z INDEX
ABOUT IAC
IAC in the News
Staff
IAC History through Film
ACIP
RECOMMENDATIONS
ADOLESCENT VACCINATION
ADULT VACCINATION
ADULT VACCINATION GUIDE
ASK THE EXPERTS
Administering Vaccines
COVID-19
Hepatitis B
MMR
Storage and Handling
>> view all
BECKY PAYNE AWARD
BILLING & CODING
BIRTH DOSE GUIDEBOOK
CALENDAR OF EVENTS
CDC INFORMATION
CDC SCHEDULES
CLINIC TOOLS
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Screening for Contraindications
Storage & Handling
Vaccine Recommendations
>> view all
COALITIONS FOR
IMMUNIZATION
CONTRIBUTE TO IAC
COVID-19 RELATED
Ask the Experts: COVID-19
Vaccines: COVID-19
DEAR COLLEAGUE LETTERS
16-year-old Visit
HPV
MenACWY Dose #2
DONATE TO IAC
EDUCATIONAL MATERIALS
EMAIL NEWS SERVICES
E-NEWSLETTER: IZ EXPRESS
EXEMPTIONS
FAQs
FAVORITES
FDA PACKAGE INSERTS
FILMS ABOUT IAC
GIVE BIRTH TO THE
END OF HEP B
HANDOUTS FOR
PATIENTS & STAFF
View All Materials
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Contraindications / Precautions
Documenting Vaccination
Healthcare Personnel
Managing Vaccine Reactions
Parent Handouts
Pregnancy and Vaccines
Q&As: Diseases and Vaccines
Schedules for Patients
Screening Checklists
Standing Orders Templates
Storage & Handling
Strategies & Policies
Temperature Logs
Top Handouts
Vaccine Confidence
Vaccine Recommendations
>> view all
HEP B BIRTH DOSE
HONOR ROLLS
Hep B Birth Dose
Mandatory Flu Vaccination for HCP
MenB Vaccination for Colleges
IZ EXPRESS
Subscribe to IZ Express
IMAGE LIBRARY
LAWS AND MANDATES
MANUFACTURERS
MASS VACCINATION
RESOURCES
NATIONAL ADULT &
INFLUENZA
IMMUNIZATION SUMMIT
NEWS & INFORMATION
NEWSLETTER SIGN UP
OFFICIAL RELEASES
ACIP
CDC
FDA
PACKAGE INSERTS
PARTNERS
PHARMACISTS
PHOTOS
PREGNANCY AND
VACCINES
PRESS ROOM
PROTECT NEWBORNS
FROM HEP B
PUBLICATIONS
IZ Express
Vaccinating Adults:
   A Step-by-Step Guide
Hepatitis B What Hospitals
   Need to Do to
   Protect Newborns
Needle Tips Archive
Vaccinate Adults Archive
Vaccinate Women Archive
REGISTRIES
SCHOOL VACCINATION REQUIREMENTS
SHOP IAC
DVD Immunization Techniques
Laminated Schedules
Patient Record Cards
Flu Vaccine Buttons and Stickers
"Vaccines Save Lives" Pins
SITE MAP
STANDING ORDERS
STATE INFORMATION
Immunization Websites
Laws and Mandates for School Entry
Immunization Program Managers
SUBSCRIBE TO IZ EXPRESS
SUPPORT IAC
TALKING ABOUT VACCINES
Adjuvants & Ingredients
Autism
Importance of Vaccination
MMR Vaccine
Religious Concerns
Vaccine Safety
>> view all
TECHNICALLY SPEAKING
(ARCHIVE)
TRANSLATIONS
IAC Handouts
VISs
TRAVEL (INTERNATIONAL)
UNPROTECTED PEOPLE
STORIES
Chickenpox
Hepatitis B
Measles
Whooping Cough
>> view all
VACCINATING ADULTS:
A STEP-BY-STEP GUIDE
VACCINE INFORMATION
STATEMENTS
Translations
VACCINE
MANUFACTURERS
VACCINE POLICY &
LICENSURE
ACIP
FDA
WHO
VACCINE SAFETY
VACCINE TIMELINE
VACCINES
COVID-19
Hepatitis B
HPV (Human papillomavirus)
Influenza
Monkeypox (mpox)
Pertussis
Varicella
>> view all
VIDEO OF THE WEEK
VIDEO LIBRARY
VISs
Translations
WHAT'S NEW OR UPDATED AT IAC
Handouts
VISs and Translations
Web Pages
 
Immunize.org  •  2136 Ford Parkway  •  Suite 5011  •  Saint Paul, Minnesota  •  55116
tel 651-647-9009  •  fax 651-647-9131
•
•
 
 
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 1NH23IP922654) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.